What is Revel Pharmaceuticals worth?
$15.0Mlast known valuation
Revel Pharmaceuticals last raised $5.8M in its Early Stage VC (Feb 2022).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Revel Pharmaceuticals
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2022 | Early Stage VC | $5.8M | ▮ | ▮ |
| Mar 2021 | Seed Round | $800K | ▮ | ▮ |
| Dec 2019 | Seed Round | $533K | ▮ | ▮ |
How Revel Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Revel Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Revel Pharmaceuticals worth?
- Revel Pharmaceuticals's last known valuation is $15.0M.
- How much has Revel Pharmaceuticals raised?
- Revel Pharmaceuticals has raised $14.7M in total funding across 3 recorded rounds.
- When did Revel Pharmaceuticals last raise?
- Revel Pharmaceuticals last raised in Feb 2022 (Early Stage VC), raising $5.8M.